Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Co-CEO & Chairman acquired 550,000 shares (grant or award)
  4. 4 Grant or award Co-CEO & President acquired 530,000 shares (grant or award)
  5. 4 Grant or award Director acquired 113,250 shares (grant or award)
  6. 4 Grant or award Director acquired 67,500 shares (grant or award)
  7. 4 Grant or award Director acquired 111,750 shares (grant or award)
  8. 4 Grant or award Director acquired 81,000 shares (grant or award)
  9. 4 Grant or award Director acquired 99,750 shares (grant or award)
  10. 4 Grant or award Director acquired 81,000 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 160,000 shares (grant or award)
  12. 4 Grant or award Director acquired 113,250 shares (grant or award)
  13. 4 Open-market sale Director sold 45,873 shares at $1.48 ($67,892)
  14. 4 Open-market sale Director sold 23,818 shares at $1.50 ($35,727)
  15. 4 Grant or award Director acquired 90,000 shares (grant or award)
  16. 4 Grant or award Director acquired 90,000 shares (grant or award)
  17. 4 Grant or award Director acquired 133,000 shares (grant or award)
  18. 4 Grant or award Director acquired 133,000 shares (grant or award)
  19. 4 Grant or award Director acquired 131,000 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 110,000 shares (grant or award)

Page 5 of 18 · 352 filings